Source: FDA, National Drug Code (US) Revision Year: 2016
ZYMAXID is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic gram-positive bacteria:
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus mitis group*
Streptococcus oralis*
Streptococcus pneumoniae
Aerobic gram-negative bacteria:
Haemophilus influenzae
Efficacy for these organisms were studied in fewer than 10 infections.
Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.
Day 2 through Day 7: Instill one drop two to four times daily in the affected eye(s) while awake.
Store at 15°-25°C (59°-77°F). Protect from freezing.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
